Bhae.Ns
BHAE.NS is a specialty chemicals company that generates revenue primarily through the production and sale of chemical products.
Business. BHAE.NS is a specialty chemicals company that generates revenue primarily through the production and sale of chemical products.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
BHAE.NS is a specialty chemicals company that generates revenue primarily through the production and sale of chemical products.
BHAE.NS has a conservative capital structure with a debt-to-equity ratio of 0.08, indicating a strong equity position relative to its liabilities. The company's liquidity is assessed as medium, with a current ratio of 2.68, suggesting it can cover its short-term obligations but with limited excess capacity. However, the company's cash and equivalents are reported as negative INR 1,000, which, when combined with its long-term debt of INR 463,058,000, results in a net cash position that is negative after subtracting total debt.
In terms of profitability, BHAE.NS reports a return on equity (ROE) of 7.24% and a return on assets (ROA) of 5.51%. These figures are below the typical thresholds for high-performing specialty chemical firms, indicating that the company is generating returns, but not at a level that would be considered exceptional within its industry.
The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. This lack of diversification may expose BHAE.NS to higher operational and market risks if demand for its primary product lines fluctuates. There is no geographic breakdown provided, so it is unclear whether the company has significant exposure to any particular region or market.
Looking ahead, BHAE.NS is expected to maintain a stable revenue trajectory, with no significant growth or decline projected in the next fiscal year. The company's operating income and net income have remained relatively consistent, suggesting a stable but not rapidly growing business model. The company's capital expenditures are negative, indicating that it is not investing in new long-term assets at this time, which may limit future growth potential.
The risk assessment for BHAE.NS highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could pose a challenge in the event of unexpected cash flow disruptions. However, the dilution risk is low, as there is no indication of significant share issuance or dilution potential in the near term.
Recent filings and transcripts do not indicate any major events or strategic shifts for BHAE.NS. The company appears to be operating within its established business model without significant new initiatives or challenges being disclosed.
- BHAE.NS maintains a conservative capital structure with a low debt-to-equity ratio of 0.08.
- The company's return on equity (7.24%) and return on assets (5.51%) are below industry benchmarks for high-performing specialty chemical firms.
- BHAE.NS has a medium liquidity risk due to a current ratio of 2.68 and a negative net cash position after subtracting total debt.
- The company's revenue is concentrated in a single business segment, with no geographic diversification disclosed.
- BHAE.NS is expected to maintain a stable revenue trajectory with no significant growth or decline projected in the next fiscal year.
- The company's dilution risk is low, with no indication of significant share issuance or dilution potential in the near term.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- BHAE.NS Market data — financials · 2026-05-27